Orthopedic Biomaterial Market

The orthopedic biomaterial market refers to the industry of orthopedic surgical and treatment devices and materials. Metal and polymeric implants, such as artificial joints and spinal devices, as well as biologic materials such as bone grafts, are examples of these materials. Related technologies, such as computer-assisted surgery and tissue engineering, are also included in the market. The market is expanding due to an ageing population and an increase in age-related musculoskeletal disorders.

The Global Orthopedic Biomaterial Market was valued at USD **Million in 2018 and is expected to grow at a CAGR of **% to USD **Million by 2031.

The use of 3D printing to create custom implants, the development of biodegradable and bioabsorbable materials, and the use of growth factors and stem cells to enhance the healing process are some of the most recent trends in the orthopedic biomaterial market. Minimally invasive surgical techniques are in high demand, as is a focus on patient-specific solutions.

Some of the Major key Players are Stryker (US), CoorsTek Inc. (US), Zimmer Biomet Holdings Inc. (US), Institut Straumann AG (Switzerland), Kyocera Corporation (Japan), Smith & Nephew plc (UK), 3M (US), Nobel Biocare Services AG(Switzerland), Medtronicplc (Ireland), and DePuy Synthes (US).